Fate Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $399k | 316k | 1.26 |
| 2025-06-30 | $326k | 291k | 1.12 |
| 2025-03-31 | $231k | 292k | 0.79 |
| 2024-12-31 | $484k | 293k | 1.65 |
| 2024-09-30 | $1.0M | 299k | 3.50 |
| 2024-06-30 | $1.2M | 374k | 3.28 |
| 2024-03-31 | $2.2M | 302k | 7.34 |
| 2023-12-31 | $1.2M | 322k | 3.74 |
| 2023-09-30 | $663k | 313k | 2.12 |
| 2023-06-30 | $1.5M | 324k | 4.76 |
| 2023-03-31 | $2.0M | 355k | 5.70 |
| 2022-12-31 | $3.7M | 363k | 10.09 |
| 2022-09-30 | $8.5M | 390k | 21.86 |
| 2022-06-30 | $8.6M | 351k | 24.63 |
| 2022-03-31 | $14M | 355k | 38.68 |
| 2021-12-31 | $22M | 358k | 61.73 |
| 2021-09-30 | $20M | 343k | 59.27 |
| 2021-06-30 | $28M | 328k | 86.79 |
| 2021-03-31 | $25M | 304k | 82.45 |
| 2020-12-31 | $29M | 315k | 90.93 |
| 2020-09-30 | $13M | 316k | 39.97 |
| 2020-06-30 | $19M | 284k | 66.67 |
| 2020-03-31 | $6.3M | 284k | 22.21 |
| 2019-12-31 | $4.7M | 239k | 19.57 |
| 2019-09-30 | $3.4M | 219k | 15.53 |
| 2019-06-30 | $4.7M | 232k | 20.30 |
| 2019-03-31 | $4.4M | 251k | 17.57 |
| 2018-12-31 | $3.2M | 246k | 12.84 |
| 2018-09-30 | $4.3M | 267k | 16.29 |
| 2018-06-30 | $3.3M | 291k | 11.34 |
| 2018-03-31 | $2.7M | 277k | 9.76 |
| 2017-12-31 | $931k | 153k | 6.11 |
| 2017-06-30 | $512k | 158k | 3.25 |
| 2017-03-31 | $271k | 60k | 4.56 |
| 2016-12-31 | $146k | 59k | 2.50 |
| 2016-09-30 | $191k | 61k | 3.12 |
| 2016-06-30 | $116k | 68k | 1.69 |